Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - large image1
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - image1
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - image2
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - image3
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - image4
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - image5
Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 buy - image6

Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2

TDS 2099 Inquiries

Unit Price:

$40-50/MT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shenzhen

Brand:

MT

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg/vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents
Qualification:
Main Products:

Retatrutide/Tirzepatide/GHK-CU/MT2(Melanotan 2 Acetate)/MOTS-C,Semaglutide,Dsip,GHK-CU,NAD+

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


    Seller Information 


    Name:mercy
    Whatsapp:+85262722358
    Email:admin@hangzhoumingtai.com


       Product Detail   


    Shop Peptide raw material High-quality Retatrutide freeze-dried powder for daily lab experiments-Detailed Image 1

    Main effects and therapeutic efficacy
    Significant weight loss effect: In the 3-phase clinical trial (TRIUMPH-1) targeting obese adults, patients receiving a once-weekly 12mg dose treatment experienced an average weight loss of 28.3% (approximately 31.9 kilograms) over 80 weeks, and a further 30.3% reduction over the 104-week follow-up period. Nearly half (45.3%) of the subjects using the highest dose lost more than 30% of their weight, achieving results comparable to those of weight loss metabolic surgery.
    Strong glycemic control: For patients with type 2 diabetes, after 40 weeks of medication, the average glycated hemoglobin decreased by 1.7% to 2.0%, and 85% of the patients achieved blood sugar control (HbA1c ≤ 6.5%), with an average weight loss of 16.8%.
    Multiple health benefits: In addition to weight loss and blood sugar control, this drug can also improve obesity-related complications, such as a reduction of approximately 73% in knee osteoarthritis pain scores, a reduction of approximately 61% in moderate to severe obstructive sleep apnea events, and significant improvement in cardiovascular risk indicators such as blood pressure and lipid levels.
    Drug mechanism: It is a "three G" receptor, simultaneously activating three receptors: glucagon (GCG), glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), through a triple mechanism to inhibit appetite, enhance metabolism, and regulate blood sugar.

    Shop Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2-Detailed Image 2

    Items Specifications
    Product name retatrutide
    Molecular formula C221H342N46O68(free)
    Purity (HPLC): 

    ≥99.0%

    CAS No.

    2381089-83-2

    Molecular Weight

    4813.527g/mol

    Storage

    Dry and Cool Place

    Grade

    Pharmaceutical Grade




      Product Safety and side effects


    Common reactions: The safety profile is similar to that of existing GLP-1 drugs (such as semaglutide), with the most common adverse events being gastrointestinal reactions, including nausea (about 42%), diarrhea (about 32%), constipation, and vomiting, mostly mild to moderate.
    Drug discontinuation: The proportion of patients discontinuing due to adverse reactions was approximately 11.3% in the highest dose group, mainly during the dose escalation phase, and the overall tolerance was good.
    Special attention: Some patients may experience skin sensory abnormalities, site reactions, or hypotension. Patients using antihypertensive drugs need to be vigilant about blood pressure changes. Currently, no new major safety signals have been identified.

    Shop Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2-Detailed Image 3

    Shop Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2-Detailed Image 4 Shop Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2-Detailed Image 5 Shop Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2-Detailed Image 6 Shop Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2-Detailed Image 7


      FAQ 


    Q1. How do you ensure product quality?
    A1. We have a strict quality management system in place. All batches must pass tests and meet our standards before being released into the warehouse.


    Q2: Why should you buy from us instead of other suppliers?

    A2: Because we are a factory, we can provide lower prices and guaranteed quality. We have extensive experience in domestic and foreign trade and provide services in an honest, timely and efficient manner.


    Q3: How to place an order for each product?

    A3: Please send us an inquiry and let us know your requirements; we will send you a complete quotation including freight, confirm the order and send payment/deposit, we will arrange production or delivery of the goods after receiving the bank receipt.


    Q4: Do you have stock?
    A4: We understand most customers prefer stock, so we'll try to keep stock for most products. However, for some rare products, we won't keep stock and it needs time to synthesize.


    Shop Peptide raw material High-quality Retatrutide freeze-dried powder for daily lab experiments-Detailed Image 6


      Shipping  


    Shop Peptide raw material High-quality Retatrutide freeze-dried powder for daily lab experiments-Detailed Image 7


    Company Introduction


    Shop Peptide raw material High-quality Retatrutide freeze-dried powder for daily lab experiments-Detailed Image 8

    Our company has been deeply engaged in the field of bioactive peptides for many years in China. We are a high-tech origin enterprise integrating R&D, large-scale production, customized processing, and global sales. We focus on the research and production of high-quality animal and plant active peptides, cosmetic synthetic peptides, and medical-grade multi-peptide raw materials. The company always takes technological innovation as its core competitiveness. We have established a professional peptide research laboratory and a professional R&D team composed of senior engineers in bioengineering, food science, and fine chemical fields. We focus on core technologies such as peptide molecule extraction, enzymatic hydrolysis purification, active component retention, and molecular modification.
    Quality is the foundation for the enterprise's survival. The factory has established a full-chain quality control management system from raw material procurement, production processing, finished product testing, storage and logistics. We have set up an independent third-party standard testing laboratory and equipped with precision detection equipment such as high-performance liquid chromatography and mass spectrometry. We conduct comprehensive and strict testing on the purity, molecular weight, microbial indicators, heavy metal content, and active components of each batch of products. Any non-compliant products will be strictly prevented from leaving the warehouse.
    As a source manufacturer, we provide customers with factory direct supply, instant delivery of stock, customized research and development, brand licensing and processing, and technical empowerment one-stop services. We can customize peptide raw materials with specific molecular weight, purity, and flavor according to customer needs. At the same time, we provide value-added services such as raw material formula adaptation, application technology guidance, and sample trial use.
    In the future, our company will continue to focus on the technological innovation of biopeptides, optimize production processes, expand production capacity matrices, and enrich product categories. With high-quality, cost-effective, and highly adaptable peptide raw materials, we will help the global health and beauty biotechnology industry achieve high-quality development. We are dedicated to providing reliable raw material supply and professional supporting services to overseas partners.

    Shop Peptide raw material High-quality Retatrutide freeze-dried powder for daily lab experiments-Detailed Image 9

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • Tirzepatide 99%;weight loss;high quality weight loss Peptide Tirzepatide 2023788-19-2 Certificates 1 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide/Tirzepatide/GHK-CU/MT2(Melanotan 2 Acetate)/MOTS-C,Semaglutide,Dsip,GHK-CU,NAD+

    Location:

    No. G0654, Tong'an Road, Shuangxi Village, Disan Town, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents

    Year of Establishment:

    2025

  • Inquiry History
    2099 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    United States

    Tirzepatide

    50 MG Oct 20, 2026
    Spain

    tirzepatide

    20 MG Oct 19, 2026
    United States

    tirzepatide

    30 MG Oct 19, 2026
    Philippines

    tirzepatide

    40 MG Oct 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.